Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis
Key Data:
Drug (brand / generic)
Mylinax (a proprietary oral formulation of cladribine)
Company / licensee
IVAX Corporation, Serono
Therapy class
Immunomodulatory agent
Product description
Lymphocytotoxic agent
Current indication
Treatment of multiple sclerosis
Market sector
CNS
Development status
Phase III
